Medical Forces Join to Develop Novel Antibody Treatments for Cancer
The OA Online website reported that HiFiBio Therapeutics announced the formation of Victa Biotherapeutics, a joint venture with Dr. Vikas P. Sukhatme. The new open-innovation collaboration will look to expand on the immuno-oncology research pioneered by Dr. Sukhatme. This new joint venture and licensing agreement is an initiative to deepen their commitment to these open-innovation collaborations that are designed to transform treatment for complex diseases and diverse tumor types. HiFiBiO Therapeutics aspires to address unmet medical needs around the world through open-innovation partnerships with industry and academia.
Click here to read the full article.